Apotheken-Nachrichten von heute: Zwischen Hochwasser, Rezeptbetrug und Wirtschaftlichen Unsicherheiten
Treten Sie ein in die Welt der Apotheken, wo jeder Tag eine neue Herausforderung birgt und jeder Erfolg ein Triumph über…
KYAN Technologies, Alentis Therapeutics, and CELLphenomics Join Forces Combining Cutting-edge Optim.AI™ and PD3D® Models to Advance Claudin-1 Expression Research
KYAN Technologies, a vanguard combinatory drug development solutions provider, is thrilled to announce a strategic partn…
REPO-TRIAL approaches conclusion: European drug repurposing at its best
As REPO-TRIAL, the EU-funded Horizon2020 project that develops innovative in-silico based approaches to improve the effi…
EMBL-Research: The impact of drugs on gut microbes is greater than we thought
We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like type 2 diabe…
![vcsPRAsset_3522216_725727_48ce84b2-0c08-4221-8771-566464115d2f_0[1].jpg](https://cdn.pressebox.de/r/73b9382d0ea1421e/attachments/12/73/82/thumbnail_1273823_552x345.jpg)
Immunic, Inc. Announces First Patients Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of IMU-838 in Combination with Oseltamivir for the Treatment of Patients with Moderate-to-Severe COVID-19
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral thera…
Gustave Roussy et Biognosys annoncent leur partenariat
La pneumonie sévère chez les patients atteints du syndrome respiratoire aigu sévère du corovinarus-2 (SARS-Cov-2) requie…
Gustave Roussy and Biognosys Announce Partnership
The severe pneumonitis in patients infected by the severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) requires…
Vom Krebsmedikament zum Antibiotikum
Das Bakterium Staphylococcus aureus kann in der normalen bakteriellen Gemeinschaft des Körpers vorkommen, aber auch schw…
Lonza Continues Strong Momentum in Businesses Along the Healthcare Continuum in Q3 2018 and Confirms Positive Outlook for the Full Year
Businesses in Pharma & Biotech and in Consumer Health – including capsule and combined ingredient and dosage form offeri…
Maschinelles Lernen für die Wirkstoff-Forschung
Neue Medikamente kostengünstiger und schneller entwickeln mit Hilfe von bildbasierten Analysen – dafür vergibt der Europ…
